Oct 10, 2017 Cellectar Biosciences Announces $7.76 Million Registered Direct Offering Priced At-The-Market Learn More
Oct 10, 2017 Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates Learn More
Sep 27, 2017 Cellectar Biosciences Reports Cohort Four Data and Partial Response in Relapsed or Refractory Multiple Myeloma Patient Treated with CLR 131 Learn More